Another acquisition this year- Sanofi partnered with ProventionBio a month prior to FDA approval of their first drug TZIELD, Sanofi used their sales force to get TZIELD up and running, then few months later acquired the whole company for US$2.9 billion. The pipeline also included a drug in phase 3, a drug in phase 2, and one drug with 3 indications each in phase 1.
Another acquisition this year- Sanofi partnered with...
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
36.8¢ |
Change
-0.008(2.00%) |
Mkt cap ! $669.7M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 38.0¢ | 36.5¢ | $701.8K | 1.886M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 16 | 558973 | 36.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.0¢ | 318337 | 11 |
View Market Depth
| Last trade - 11.36am 30/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |